PTH and secondary hyperparathyroidism: This treatment sequence underscores the challenges of maintaining a balance between calcium and PTH levels, requiring ongoing adjustments in response to biochemical changes, allowing for effective management of both primary and secondary hyperparathyroidism, with treatment decisions guided by serial monitoring and alignment with Kidney Disease: Improving Global Outcomes (KDIGO) recommendations [3].